Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and Inflammation

• Published in: Journal of Cancer 2015-01, Vol.6 (10), p.938-952
• Main Authors: Rivas-Fuentes, Selma, Salgado-Aguayo, Alfonso, Pertuz Belloso, Silvana, Gorocica Rosete, Patricia, Alvarado-Vásquez, Noé, Aquino-Jarquin, Guillermo
• Format: Article
• Language: English
• Subjects: Review
• ISSN: 1837-9664; 1837-9664
• DOI: 10.7150/jca.12286

Non-small cell lung cancer (NSCLC) is one of the most common types of aggressive cancer. The tumor tissue, which shows an active angiogenesis, is composed of neoplastic and stromal cells, and an abundant inflammatory infiltrate. Angiogenesis is important to support tumor growth, while infiltrating cells contribute to the tumor microenvironment through the secretion of growth factors, cytokines and chemokines, important molecules in the progression of the disease. Chemokines are important in development, activation of the immune response, and physiological angiogenesis. Chemokines have emerged as important regulators in the pathophysiology of cancer. These molecules are involved in the angiogenesis/angiostasis balance and in the recruitment of tumor infiltrating hematopoietic cells. In addition, chemokines promote tumor cell survival, as well as the directing and establishment of tumor cells to metastasis sites. The findings summarized here emphasize the central role of chemokines as modulators of tumor angiogenesis and their potential role as therapeutic targets in the inflammatory process of NSCLC angiogenesis.